Fas ligand as a tool for immunosuppression and generation of immune tolerance

Osnat Bohana-Kashtan, Curt I. Civin

Research output: Contribution to journalArticle

Abstract

The role of Fas ligand (FasL) in physiologically limiting immune responses and maintaining immune-privileged sites has led to a body of research aiming to confer protection to allogeneic grafts by expressing FasL on the allogeneic tissue or by administrating FasL-transduced donor dendritic cells. In addition, several studies have used FasL to abrogate autoimmune responses. This review presents the results of these studies and discusses the problems associated with FasL usage.

Original languageEnglish (US)
Pages (from-to)908-924
Number of pages17
JournalStem Cells
Volume22
Issue number6
StatePublished - 2004

Fingerprint

Immune Tolerance
Fas Ligand Protein
Immunosuppression
Autoimmunity
Dendritic Cells
Transplants
Research

Keywords

  • Allogeneic
  • Dendritic cells
  • Fas ligand(FasL)
  • gld
  • Immune privilege
  • lpr
  • Tolerance

ASJC Scopus subject areas

  • Cell Biology

Cite this

Bohana-Kashtan, O., & Civin, C. I. (2004). Fas ligand as a tool for immunosuppression and generation of immune tolerance. Stem Cells, 22(6), 908-924.

Fas ligand as a tool for immunosuppression and generation of immune tolerance. / Bohana-Kashtan, Osnat; Civin, Curt I.

In: Stem Cells, Vol. 22, No. 6, 2004, p. 908-924.

Research output: Contribution to journalArticle

Bohana-Kashtan, O & Civin, CI 2004, 'Fas ligand as a tool for immunosuppression and generation of immune tolerance', Stem Cells, vol. 22, no. 6, pp. 908-924.
Bohana-Kashtan, Osnat ; Civin, Curt I. / Fas ligand as a tool for immunosuppression and generation of immune tolerance. In: Stem Cells. 2004 ; Vol. 22, No. 6. pp. 908-924.
@article{2b5b8ff559314895a1b14ac39d57099f,
title = "Fas ligand as a tool for immunosuppression and generation of immune tolerance",
abstract = "The role of Fas ligand (FasL) in physiologically limiting immune responses and maintaining immune-privileged sites has led to a body of research aiming to confer protection to allogeneic grafts by expressing FasL on the allogeneic tissue or by administrating FasL-transduced donor dendritic cells. In addition, several studies have used FasL to abrogate autoimmune responses. This review presents the results of these studies and discusses the problems associated with FasL usage.",
keywords = "Allogeneic, Dendritic cells, Fas ligand(FasL), gld, Immune privilege, lpr, Tolerance",
author = "Osnat Bohana-Kashtan and Civin, {Curt I.}",
year = "2004",
language = "English (US)",
volume = "22",
pages = "908--924",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "AlphaMed Press",
number = "6",

}

TY - JOUR

T1 - Fas ligand as a tool for immunosuppression and generation of immune tolerance

AU - Bohana-Kashtan, Osnat

AU - Civin, Curt I.

PY - 2004

Y1 - 2004

N2 - The role of Fas ligand (FasL) in physiologically limiting immune responses and maintaining immune-privileged sites has led to a body of research aiming to confer protection to allogeneic grafts by expressing FasL on the allogeneic tissue or by administrating FasL-transduced donor dendritic cells. In addition, several studies have used FasL to abrogate autoimmune responses. This review presents the results of these studies and discusses the problems associated with FasL usage.

AB - The role of Fas ligand (FasL) in physiologically limiting immune responses and maintaining immune-privileged sites has led to a body of research aiming to confer protection to allogeneic grafts by expressing FasL on the allogeneic tissue or by administrating FasL-transduced donor dendritic cells. In addition, several studies have used FasL to abrogate autoimmune responses. This review presents the results of these studies and discusses the problems associated with FasL usage.

KW - Allogeneic

KW - Dendritic cells

KW - Fas ligand(FasL)

KW - gld

KW - Immune privilege

KW - lpr

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=8644250720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8644250720&partnerID=8YFLogxK

M3 - Article

C2 - 15536183

AN - SCOPUS:8644250720

VL - 22

SP - 908

EP - 924

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 6

ER -